Inoue T - Search Results

1

Association Between Blood Pressure Lowering and Quality of Life by Treatment of Azilsartan.

Fujiwara N, Tanaka A, Kawaguchi A, Tago M, Oyama JI, Uchida Y, Matsunaga K, Moroe K, Toyoda S, Inoue T, Ikeda H, Node K; APEQ Study Investigators. Fujiwara N, et al. Among authors: inoue t. Int Heart J. 2017 Oct 21;58(5):752-761. doi: 10.1536/ihj.16-511. Epub 2017 Sep 30. Int Heart J. 2017. PMID: 28966324 Free article. Clinical Trial.

2

Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation.

Inoue T, Uchida T, Sakuma M, Imoto Y, Ozeki Y, Ozaki Y, Hikichi Y, Node K. Inoue T, et al. J Am Coll Cardiol. 2004 Oct 6;44(7):1408-14. doi: 10.1016/j.jacc.2004.06.066. J Am Coll Cardiol. 2004. PMID: 15464320 Free article. Clinical Trial.

3

Therapeutic potential of monteplase in acute myocardial infarction as a powerful thrombolytic agent for pretreatment of coronary intervention.

Inoue T, Nishiki R, Kageyama M, Node K. Inoue T, et al. Cardiovasc Drug Rev. 2004 Winter;22(4):320-33. doi: 10.1111/j.1527-3466.2004.tb00149.x. Cardiovasc Drug Rev. 2004. PMID: 15592577 Review.

4

Long-term benefits of monteplase before coronary angioplasty in acute myocardial infarction.

Inoue T, Nishiki R, Kageyama M, Chida R, Hayashi T, Takayanagi K, Hikichi Y, Node K. Inoue T, et al. Am J Cardiol. 2005 Feb 15;95(4):506-8. doi: 10.1016/j.amjcard.2004.09.061. Am J Cardiol. 2005. PMID: 15695140 Clinical Trial.

5

Therapeutic potential of monteplase in acute myocardial infarction.

Inoue T, Nishiki R, Kageyama M, Node K. Inoue T, et al. Am J Cardiovasc Drugs. 2005;5(4):225-31. doi: 10.2165/00129784-200505040-00002. Am J Cardiovasc Drugs. 2005. PMID: 15984905 Review.

6

An appropriate indication for the initiation of beta-blocker therapy in dilated cardiomyopathy.

Morooka T, Inoue T, Kotooka N, Fujimatsu D, Komatsu A, Uchida F, Yoshida K, Hashimoto S, Hikichi Y, Kato T, Node K. Morooka T, et al. Among authors: inoue t. Cardiology. 2006;105(1):61-6. doi: 10.1159/000089295. Epub 2005 Nov 1. Cardiology. 2006. PMID: 16272814

7

Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease.

Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Inoue T, Node K. Nakamura T, et al. Among authors: inoue t. Am J Nephrol. 2006;26(1):82-6. doi: 10.1159/000091956. Epub 2006 Mar 9. Am J Nephrol. 2006. PMID: 16534182 Clinical Trial.

8

Low-density lipoprotein subfractions and the prevalence of silent lacunar infarction in subjects with essential hypertension.

Kato T, Inoue T, Yamagishi S, Morooka T, Okimoto T, Node K. Kato T, et al. Among authors: inoue t. Hypertens Res. 2006 May;29(5):303-7. doi: 10.1291/hypres.29.303. Hypertens Res. 2006. PMID: 16832149

9

Atorvastatin inhibits angiotensin II-induced T-type Ca2+ channel expression in endothelial cells.

Wang D, Hirase T, Inoue T, Node K. Wang D, et al. Among authors: inoue t. Biochem Biophys Res Commun. 2006 Aug 25;347(2):394-400. doi: 10.1016/j.bbrc.2006.06.084. Epub 2006 Jun 22. Biochem Biophys Res Commun. 2006. PMID: 16842760

10

Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers.

Kato T, Inoue T, Morooka T, Yoshimoto N, Node K. Kato T, et al. Among authors: inoue t. Can J Physiol Pharmacol. 2006 May;84(5):523-9. doi: 10.1139/y06-030. Can J Physiol Pharmacol. 2006. PMID: 16902597 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,882 results

Search Page

Filters